Synthetic Biologics (SYN) Misses Q4 EPS by 42c

Synthetic Biologics (NYSE: SYN) reported Q4 EPS of ($0.54), $0.42 worse than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Synthetic Biologics (SYN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
• CoStar Group acquires Zonda for $800M, adding new home data